Rhythm Versus Rate Control in Patients with Atrial Fibrillation – Pharmacist, Nurse, Nurse Practitioner

  Price  $6.95

  Credits  1.5

Clear


Format

More than 454,000 hospitalizations happen annually in the United States, with atrial fibrillation (AF) as the primary diagnosis making AF the most common cardiac arrhythmia in clinical practice today. In the following decades, it is anticipated that the prevalence of AF will double, increasing with age and becoming a more significant medical burden on a global scale. The goal of this review is to assist the readers in recalling the history, classifications, current drug therapies, and nonpharmacological approaches that have been recently added to the updated guidelines for the management of AF.

$6.95

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharmacist

Nurse Practitioner

Nurse

Author

Saeed Khaja
DO
Donna Lisi
BS Pharmacy, BCPS, BCGP, BCACP, BCPP, BCMTMS
Saeed Khaja
DO
Fatima Khaja
CDE, PharmD. Ph.D.
Donna Lisi
BS Pharmacy, BCPS, BCGP, BCACP, BCPP, BCMTMS
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Pharmacist

Pharmacist

  • Recall the classifications, pathophysiology, and risk factors of AF
  • Distinguish between rhythm and rate control in AF
  • List antiarrhythmic treatments used to maintain sinus rhythm control in AF
  • Identify agents and procedures used to control ventricular rate in patients with AF
  • Determine the choice of therapy based on the patient's needs and type of AF
  • Summarize recommended patient counseling and education by clinical pharmacists for patients with AF 

Nurse Practitioner

Nurse Practitioner

  • Recall the classifications, pathophysiology, and risk factors of AF
  • Distinguish between rhythm and rate control in AF
  • List antiarrhythmic treatments used to maintain sinus rhythm control in AF
  • Identify agents and procedures used to control ventricular rate in patients with AF
  • Determine the choice of therapy based on the patient's needs and type of AF
  • Summarize recommended patient counseling and education by clinical pharmacists for patients with AF 

Nurse

Nurse

  • Recall the classifications, pathophysiology, and risk factors of AF
  • Distinguish between rhythm and rate control in AF
  • List antiarrhythmic treatments used to maintain sinus rhythm control in AF
  • Identify agents and procedures used to control ventricular rate in patients with AF
  • Determine the choice of therapy based on the patient's needs and type of AF
  • Summarize recommended patient counseling and education by clinical pharmacists for patients with AF 

Course Accreditation

  • Activity Type:
  • CE Broker
    20-1085748
  • Universal Activity Number:
    Nurse : 0798-0000-23-229-H01
    Pharmacist : 0798-0000-23-229-H01-P
    Nurse Practitioner : 0798-0000-23-229-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

Credit for this program is issued by passing the final test hosted at www.RxConsultant.com with a score of 70% or higher.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.